Massivemarkets

LGND

Ligand Pharmaceuticals Inc.

Nasdaq · usd

$316.98+2.81 (+0.90%)
As of 12:03:52 PM EST on Nov 11, 2026 · 15-minute delayed

Ligand Pharmaceuticals Inc. (LGND) trades at $316.98 (+0.90%) as of 12:03:52 PM EST on Nov 11, 2026, +4.41% over the past month. Market cap is $6.28B, with 10.5 days to cover in short interest.

Stock performance

How Ligand Pharmaceuticals Inc. (LGND) stock has performed from one day to one year, with its 52-week range.

+0.62%
+$1.96 over 1D
$315.14$316.48$317.82$319.169:20 AM10:10 AM10:50 AM11:25 AM12:00 PM$316.98
1D
+0.88%
1W
+0.25%
1M
+4.41%
YTD
+67.62%
1Y
+54.13%
52-wk range
$175.89 – $326.63

Key statistics

Today's trading snapshot for LGND: day range, open, previous close, volume and market cap.

Day range
$314.17 – $322.41
Open
$315.99
Prev close
$314.16
Volume
26.5K
Market cap
$6.28B
Shares out
20M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Ligand Pharmaceuticals Inc.: P/E, P/S, P/B, ROE and more.

P/E
122.11
P/S
24.76
P/B
6.53
P/FCF
69.34
ROE
5.3%
ROA
2.3%
Debt/Equity
1.17
Div yield
0.00%

As of Nov 10, 2026

8-K filings

Material corporate events Ligand Pharmaceuticals Inc. has disclosed to the SEC on Form 8-K.

  • Quarterly earningsOct 29, 2026

    On October 29, 2026, Ligand Pharmaceuticals Incorporated (the "Company") issued a press release announcing its financial results for the three and nine months ended September 30, 2026.

  • Merger completionJul 14, 2026

    On July 14, 2026, the Company consummated the previously announced Merger with HoldCo in accordance with the terms of the Merger Agreement. Pursuant to the Merger Agreement, XOMA Royalty effected the Holding Company Reorganization (as defined below) prior to giving effect to the Merger.

  • Warrant or conversionJun 25, 2026

    On June 22, 2026, concurrently with the pricing of the Notes, and June 23, 2026, concurrently with the initial purchasers' exercise of the option to purchase additional Notes, the Company entered into privately negotiated warrant transactions to sell to the Counterparties warrants (the "Warrants") to acquire, collectively, subject to customary anti-dilution adjustments, up to the same number of shares of Common Stock covered by the Purchased Options at an initial strike price of $524.3400 per share.

  • Private placementJun 22, 2026

    the Company issued a press release announcing the proposed offering of $550 million aggregate principal amount of convertible senior notes due 2031 (the "Notes") in a private placement (the "Offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

  • Annual meeting resultsJun 9, 2026

    The 2026 Annual Meeting of the Stockholders of Ligand Pharmaceuticals Incorporated (the "Company") was held on June 5, 2026 (the "Annual Meeting"). At the Annual Meeting, the Company's stockholders approved an amendment and restatement of the Company's 2002 Stock Incentive Plan.

Dividend history and stock splits

Ligand Pharmaceuticals Inc.'s recent dividend payments and stock splits.

Dividends

  • $0.08ex-div Jul 2, 2010
  • $2.50ex-div Apr 3, 2007

Splits

  • 1-for-6Nov 19, 2010

LGND short interest

How heavily LGND is shorted: shares short, days to cover and average daily volume.

Days to cover
10.5
Short interest
2.46M
Avg volume
234.09K

As of · reported to FINRA twice monthly.

LGND news

The latest news and headlines about Ligand Pharmaceuticals Inc. (LGND).

Frequently asked questions

What is the Ligand Pharmaceuticals Inc. (LGND) stock price today?

Ligand Pharmaceuticals Inc. (LGND) is trading at $316.98 (+0.90% on the day) as of 12:03:52 PM EST on Nov 11, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Ligand Pharmaceuticals Inc.?

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies.

What is the short interest in LGND?

As of Oct 30, 2026, LGND has 2.46M shares short and 10.5 days to cover.

Does Ligand Pharmaceuticals Inc. (LGND) pay a dividend?

Yes. Ligand Pharmaceuticals Inc. (LGND)'s most recent dividend was $0.08 per share, with an ex-dividend date of Jul 2, 2010. Full LGND dividend history is available from the Massive API.

What exchange is LGND listed on?

Ligand Pharmaceuticals Inc. (LGND) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of LGND with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a LGND analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.